Business
Nanalysis Business Update and COVID-19 Impact
Nanalysis Business Update and COVID-19 Impact Canada NewsWire CALGARY, April 6, ...
About this update from Nanalysis Scientific Corp
[{"type":"text","content":"\n\n\n\nNanalysis Business Update and COVID-19 Impact\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nCALGARY, April 6, 2020\n\n\n\nCALGARY, April 6, 2020 /CNW/ - Nanalysis Scientific Corp. (\"Nanalysis\", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) would like to provide an update on our business to our investors, given the global coronavirus pandemic.\n\n \n \n \n \n \n \n\n \nNanalysis CEO, Sean Krakiwsky states: \"We are addressing the recent outbreak of the novel coronavirus (\"COVID-19\") and the related economic and social disruption, volatility in financial markets, and potential future disruption to global supply chains. Nanalysis continues to keep a full staff complement, and for the most part continues to produce and ship product on schedule. Our supply chain has been impacted to some extent, but initial delays seem to be clearing up, allowing us to continue our sales process and deliver goods based on customer demand. Some countries, such as India, have restrictions on incoming foreign goods, but global product distribution has remained largely unaffected. Orders continue to be processed, and collaborative work with partners continues, albeit at a slightly slower rate. \n\"We are pleased to report that thus far, no members of the Nanalysis family in Canada, France, Germany, or USA have reported any positive COVID-19 tests, and we are all healthy, which is the most important thing for our business right now.\n\"The vast majority of our people are working from home, but some workers in manufacturing and product development are going in to our R&D centres and manufacturing facilities in Canada and France: While doing so, they are observing strict social distancing and density rules, as well as all recommendations of the Governments of Canada and France. Our leadership team, especially our HSE Officer, Dr. Heather Phillips, has been planning for this for over two months, and has done an incredible job of minimizing operational disruptions to the extent practically possible. As an example, on the R&D front, we remain excited about ...